Stuart Allan: An Important Translational Project In Relation to Acute Stroke Treatment
Stuart Allan, Professor of Neuroscience at The University of Manchester, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Absolutely delighted to see our latest paper online.
A really important translational project in relation to acute stroke treatment.
Well done Ioana-Emilia Mosneag – a superb effort as part of your PhD.
Also a brilliant collaboration with the stroke team in Caen and others.”
Title: Timing-Dependent Cleavage of Interleukin-1 Receptor Antagonist by Alteplase Impairs Neuroprotection in Ischemic Stroke
Authors: Ioana-Emilia Mosneag, Marina Rubio, Eloïse Lemarchand, Yolanda Ohene, Ben R. Dickie, Rachel Jones, Graham Coutts, Eleanor Ritchie, Daniela Martins Borges, Denis Vivien, Craig J. Smith, Stuart M. Allan
Read the Full Article on Stroke
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke